optimizing transfusion support in mds
Published 3 years ago • 53 plays • Length 3:02Download video MP4
Download video MP3
Similar videos
-
1:30
optimizing transfusion support for patients with mds
-
2:35
methods of optimizing transplantation in mds
-
1:29:42
optimizing transfusion support in mds
-
3:46
managing transfusion dependence in mds: lenalidomide, esas & defining a threshold for transfusion
-
1:44
imerge update: continuous transfusion independence & disease modification with imetelstat in lr-mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
11:53
the optimal treatment of lower risk mds
-
1:41
the role of antibody-based therapies in mds treatment
-
13:39
key highlights in mds: treating lower-risk & higher-risk disease, trial updates, and more
-
8:05
iron overload | haemochromatosis | randox health
-
2:52
jak inhibitor combination therapy for the treatment of myelofibrosis
-
2:15
optimizing transplantation for mds
-
3:36
the genetic landscape of mds: how this is improving & impacting the development of therapies
-
1:22
key advances in mds management
-
11:33
treatment algorithm for low-risk mds
-
1:34
personalizing treatment of transfusion-dependent anemia in lr-mds
-
1:13
the main treatment goals in lr-mds and how these differ from hr-mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
5:44
potential complications of transfusions in mds management
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
3:37
progress in the categorization and treatment of lr-mds
-
1:57
enhancing clinical care in lr-mds: managing symptomatic/transfusion-dependent anemia